Entrada Therapeutics, Inc. (TRDA) Tops Q4 EPS by 70c
Tweet
Share
E-mailGet Alerts TRDA Hot Sheet
Join SI Premium – FREE
Entrada Therapeutics, Inc. (NASDAQ: TRDA) reported Q4 EPS of $0.03, $0.70 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $37.4 million versus the consensus estimate of $13.34 million.
For earnings history and earnings-related data on Entrada Therapeutics, Inc. (TRDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- ClearSign Technologies (CLIR) Tops Q2 EPS by 8c
- Jaguar Health (JAGX) Tops Q2 EPS by 3647c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
